Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.
暂无分享,去创建一个
K. Furie | W. Ageno | G. D. De Marchis | L. Pantoni | M. Mancuso | Monica Acciarresi | V. Caso | S. Monaco | S. Engelter | K. Lees | A. Abdul-Rahim | P. Santalucia | J. Putaala | M. Zedde | G. Tsivgoulis | A. Pezzini | F. Bandini | G. Agnelli | D. Toni | A. Komnos | P. Lochner | A. Rimoldi | P. Michel | S. Yaghi | P. Bertora | S. Sohn | M. Paciaroni | F. Corea | M. Venti | D. Deleu | M. Cappellari | M. Acampa | N. Mumoli | F. Guideri | M. Del Sette | S. Marcheselli | G. Orlandi | R. Tassi | N. Giannini | L. Palaiodimou | S. Giannopoulos | E. Grifoni | O. Kargiotis | G. Ntaios | A. Katsanos | G. Martini | Brian C. Mac Grory | K. Makaritsis | M. C. Vedovati | L. Masotti | D. Seiffge | B. Bonetti | P. Pierini | A. Polymeris | A. Chiti | K. Antonenko | A. Alberti | A. Eskandari | S. Galliazzo | A. Rocco | V. Saia | A. Ciccone | M. Diomedi | M. Mannino | E. Schirinzi | A. Baldi | G. Silvestrelli | P. Papamichalis | K. Nardi | E. Giorli | B. Doronin | L. Denti | E. Toso | Kalliopi Perlepe | Efstathia Karagkiozi | F. Angelini | T. Tassinari | M. Giustozzi | A. Risitano | Nemanja Popovic | Cataldo D’Amore | E. Verrengia | Marina Padroni | M. G. Mosconi | E. Lotti | C. Liantinioti | S. Rosa | Y. Flomin | M. Žarkov | M. Maccarrone | L. Ulivi | E. Ferrari | V. Volodina | M. Vedovati | B. M. Mac Grory | Azmil H. Abdul-Rahim | A. Rimoldi
[1] C. Dolea,et al. World Health Organization , 1949, International Organization.
[2] A. Fox,et al. Accuracy and prognostic consequences of ultrasonography in identifying severe carotid artery stenosis. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. , 1995, Stroke.
[3] A. Alexandrov,et al. Correlation of peak systolic velocity and angiographic measurement of carotid stenosis revisited. , 1997, Stroke.
[4] H. A. Smith,et al. A standardized method for measuring intracranial arterial stenosis. , 2000, AJNR. American journal of neuroradiology.
[5] P. Scheltens,et al. A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.
[6] Richard Sutton,et al. International consensus on nomenclature and classification of atrial fibrillation: A collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 2003, Journal of cardiovascular electrophysiology.
[7] S. Lévy,et al. International Consensus on Nomenclature and Classification of Atrial Fibrillation: A Collaborative Project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology , 2003, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[8] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[9] S. Yusuf,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[10] M. Hennerici,et al. New Approach to Stroke Subtyping: The A-S-C-O (Phenotypic) Classification of Stroke , 2009, Cerebrovascular Diseases.
[11] W. Ageno,et al. Risk factors for cerebral ischemic events in patients with atrial fibrillation on warfarin for stroke prevention. , 2010, Atherosclerosis.
[12] P. Colonna,et al. Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC). , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[13] D. Atar,et al. Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.
[14] D. Parra,et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011 .
[15] G. Breithardt,et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.
[16] M. Hennerici,et al. The ASCOD Phenotyping of Ischemic Stroke (Updated ASCO Phenotyping) , 2013, Cerebrovascular Diseases.
[17] E. Antman,et al. Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.
[18] Alexander Parkhomenko,et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials , 2014, The Lancet.
[19] A. Alexandrov,et al. Novel oral anticoagulants for the secondary prevention of cerebral ischemia: a network meta-analysis , 2016, Therapeutic Advances in Neurological Disorders.
[20] D. Singer,et al. Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes , 2016 .
[21] P. Michel,et al. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials , 2017, International journal of stroke : official journal of the International Stroke Society.
[22] U. Ziemann,et al. Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions , 2017, Stroke.
[23] D. Singer,et al. Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II) , 2018, Journal of the American Heart Association.
[24] A. Tosetto,et al. Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme , 2018, Journal of thrombosis and haemostasis : JTH.